TMRW Life Sciences Stock

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

Sign up today and learn more about TMRW Life Sciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About TMRW Life Sciences Stock

TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics. TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.

Funding History

May 2019$12.0M
December 2019$36.5M
July 2021$105M


Founder & Co-CEO

Joshua Abram

Board Member

Emily Drabant Conley

Independent Director

Tara Comonte

Senior Vice President Of Sales

Brian E Miller

Founder & Chief Medical Officer

Jeffrey Port

Board Member

Andrew Schwab

Board Observer

Mira Chaurushiya


Melanie Goldey

Executive Board Member, Advisory Board Member; Fertiliy Tech, Fashion, VC

Robbie Myers

Board Member

David Sable

Strategic Advisor

Ellen Lubman

Board Director

Robbie Myers

Founder & Co-CEO

Alan Murray


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: